{"gene":"HP1BP3","run_date":"2026-06-10T01:55:22","timeline":{"discoveries":[{"year":2009,"finding":"HP1BP3 (HP1-BP74) middle region (residues Lys97–Lys274) associates with linker DNA at the entry/exit site of nucleosomal DNA, forming a chromatosome-like structure that protects ~25 bp of linker DNA from MNase digestion. The globular domain (Met153–Thr237) within this region adopts a structure similar to the globular domain of linker histones as determined by NMR. Full-length HP1BP3 directly binds HP1 (heterochromatin protein 1), with exact HP1-binding sites identified.","method":"NMR structure determination, MNase protection assay with reconstituted mononucleosomes, in vitro direct binding assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — NMR structure with functional validation by reconstituted in vitro nucleosome binding and MNase protection assay, multiple orthogonal methods in a single study","pmids":["20042602"],"is_preprint":false},{"year":2014,"finding":"HP1BP3 dynamically associates with chromatin during interphase progression; it maintains heterochromatin integrity during G1-S progression and regulates the duration of G1 phase to influence cell proliferative capacity.","method":"Partial MNase digestion coupled with iTRAQ quantitative proteomics, biochemical fractionation, functional cell-cycle assays (siRNA knockdown with cell-cycle analysis)","journal":"Molecular & cellular proteomics : MCP","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — quantitative chromatin proteomics combined with functional knockdown and cell-cycle readout, single lab, two orthogonal methods","pmids":["24830416"],"is_preprint":false},{"year":2014,"finding":"HP1BP3 mediates chromatin condensation during hypoxia, leading to increased tumor cell viability, radio-resistance, chemo-resistance, and self-renewal. Its chromatin association topology changes under hypoxic versus normoxic conditions.","method":"DNase I partial digestion with iTRAQ quantitative proteomics, functional assays (cell viability, clonogenic survival, sphere formation under knockdown/overexpression)","journal":"Molecular & cellular proteomics : MCP","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — quantitative chromatome profiling combined with functional loss-of-function assays, single lab, two orthogonal methods","pmids":["25100860"],"is_preprint":false},{"year":2015,"finding":"HP1BP3 is structurally related to the linker histone H1 family, containing three globular domains and a positively charged C-terminal domain. FRAP studies demonstrate that chromatin binding depends on both its C- and N-terminal regions and is regulated by cell cycle stage and post-translational modifications. HP1BP3 contains functional motifs absent from canonical H1, including an acidic stretch and a consensus HP1-binding motif. Knockdown in HeLa cells alters expression of 383 genes. Hp1bp3−/− mice exhibit 60% neonatal lethality and lifelong ~20% growth retardation.","method":"FRAP (live-cell imaging), transcriptional profiling (microarray), mouse knockout phenotyping, domain analysis/sequence comparison","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — FRAP with functional domain dissection, knockout mouse phenotype, and transcriptome profiling; single lab but multiple orthogonal methods","pmids":["25662603"],"is_preprint":false},{"year":2015,"finding":"Hp1bp3−/− mice are proportionate dwarfs with severely impaired cortical and trabecular bone development. Primary osteoblast and osteoclast cultures from Hp1bp3−/− mice showed normal differentiation, indicating the growth defect is non-cell-autonomous. These mice exhibit ~60% reduction in circulating IGF-1 and ~4-fold increase in IGFBP-1 and IGFBP-2, with corresponding changes in hepatic transcripts of Igf1, Igfbp1, and Igfbp2, implicating HP1BP3 in transcriptional regulation of the endocrine IGF-1 axis.","method":"Hp1bp3−/− mouse knockout, microCT bone analysis, primary cell culture differentiation assays, ELISA for serum IGF-1/IGFBPs, hepatic transcript quantification","journal":"Endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic loss-of-function with multiple orthogonal readouts (bone imaging, endocrine assays, transcriptomics), single lab","pmids":["26402843"],"is_preprint":false},{"year":2016,"finding":"HP1BP3 specifically associates with the Drosha-DGCR8 microprocessor complex, co-localizes genome-wide with Drosha at actively transcribed miRNA loci (by ChIP), binds endogenous pri-miRNAs, and facilitates the Drosha/pri-miRNA association in vivo. Knockdown of HP1BP3 causes premature release of nascent pri-miRNAs from chromatin, impairing global miRNA biogenesis. HP1BP3 thus functions as a chromatin retention factor for co-transcriptional miRNA processing.","method":"Co-immunoprecipitation (Co-IP), chromatin immunoprecipitation (ChIP-seq), RNA immunoprecipitation (RIP), siRNA knockdown with miRNA profiling","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP, genome-wide ChIP, RIP, and functional knockdown with miRNA profiling; multiple orthogonal methods establishing mechanism","pmids":["27425409"],"is_preprint":false},{"year":2016,"finding":"Deletion of Hp1bp3 in female mice causes failure to retrieve pups and reduced anxiety-like behavior without deficits in social behavior, depression, motor coordination, or olfactory capability, identifying a specific role for HP1BP3 in maternal and anxiety-related behavior.","method":"Hp1bp3−/− mouse knockout, pup retrieval behavioral assay, open-field and elevated-plus-maze tests, co-fostering rescue experiment","journal":"Genes, brain, and behavior","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic knockout with multiple behavioral assays and rescue experiment, single lab","pmids":["27470444"],"is_preprint":false},{"year":2016,"finding":"Deletion of functional Hp1bp3 in mice recapitulates memory deficits characteristic of aged impaired mice and humans, establishing HP1BP3 as a modulator of cognitive aging.","method":"Hp1bp3−/− mouse knockout, cognitive behavioral testing (memory assays), systems genetics using genetically diverse mouse population","journal":"Neurobiology of aging","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic knockout with cognitive behavioral phenotype in a genetically diverse mouse population, single lab","pmids":["27460150"],"is_preprint":false},{"year":2021,"finding":"HP1BP3 promotes tumor growth and metastasis in esophageal squamous cell carcinoma by upregulating miR-23a, which directly binds to the 3′UTR of TRAF5, thereby altering cell survival and proliferation downstream.","method":"HP1BP3 knockdown/overexpression in cancer cell lines and xenograft models, miR-23a profiling, 3′UTR luciferase reporter assay for TRAF5","journal":"American journal of cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional knockdown/overexpression with in vivo xenograft, luciferase reporter for direct miR-23a/TRAF5 interaction, single lab","pmids":["34249436"],"is_preprint":false},{"year":2022,"finding":"EZH2 physically interacts with HP1BP3 in glioma stem cells, and this interaction impairs H3K9 methylation. EZH2 and HP1BP3 co-activate WNT7B expression, promoting temozolomide resistance and stemness in glioblastoma cells.","method":"Co-immunoprecipitation (Co-IP) followed by mass spectrometry, transcriptomic analysis, overexpression/knockdown functional assays, WNT pathway inhibitor (LGK974) rescue","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP/MS identification of EZH2-HP1BP3 interaction, functional assays with pharmacological rescue, single lab","pmids":["36517590"],"is_preprint":false},{"year":2024,"finding":"HP1BP3 interacts with PGC7 through its central globular domain (PGC7 binds via its C-terminal tail). HP1BP3 recruits PGC7 to the Meg3 differentially methylated region (DMR) in the Dlk1-Dio3 imprinted domain. Cooperative binding of PGC7 and HP1BP3 antagonizes DNMT3A enrichment at the Meg3-DMR, maintaining DNA methylation status. Depletion of either HP1BP3 or PGC7 leads to chromosome decondensation at this region.","method":"Co-immunoprecipitation, domain-mapping interaction assays, ChIP, DNMT3A enrichment assays, bisulfite sequencing for DNA methylation, knockdown phenotyping","journal":"Journal of cellular biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP with domain mapping, ChIP, and DNA methylation analysis; single lab, multiple orthogonal methods","pmids":["39422314"],"is_preprint":false},{"year":2025,"finding":"HP1BP3 functions as a linker histone variant: it efficiently binds to nucleosome core particles (NCPs) forming a chromatosome, with a single HP1BP3 molecule binding a single NCP. Its NCP binding activity is regulated by linker histone chaperones NPM1 and TAF-I, which interact with the globular domains and C-terminal disordered region of HP1BP3. ChIP-seq shows HP1BP3 preferentially associates with genomic loci enriched for active histone H3 modification marks, in contrast to linker histone H1.2 which prefers inactive loci; these preferences are diminished upon NPM1 or TAF-I knockdown.","method":"Biochemical NCP-binding assays, chromatosome reconstitution, co-immunoprecipitation for chaperone interactions, ChIP-seq, siRNA knockdown","journal":"Epigenetics & chromatin","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution of chromatosome formation, biochemical chaperone-interaction mapping, genome-wide ChIP-seq; multiple orthogonal methods in a single rigorous study","pmids":["40140990"],"is_preprint":false}],"current_model":"HP1BP3 is a linker histone H1-like chromatin protein that binds nucleosome core particles (forming a chromatosome via its central globular domain and linker DNA contacts), whose chromatin occupancy is regulated by chaperones NPM1 and TAF-I and by cell cycle-dependent post-translational modifications; it directly binds HP1 and PGC7, recruits the Drosha-DGCR8 microprocessor to actively transcribed miRNA loci to promote co-transcriptional pri-miRNA processing by retaining nascent transcripts on chromatin, maintains heterochromatin integrity during G1-S to regulate G1 duration, cooperates with PGC7 to antagonize DNMT3A at imprinted DMRs, interacts with EZH2 to co-activate WNT7B, and is required in vivo for neonatal survival, postnatal growth (via the endocrine IGF-1 axis), cognitive function, and maternal behavior."},"narrative":{"mechanistic_narrative":"HP1BP3 is a linker histone H1-like chromatin protein that organizes higher-order chromatin and couples chromatin state to gene regulation, cell proliferation, and organismal physiology [PMID:20042602, PMID:25662603, PMID:40140990]. It binds the nucleosome core particle in a 1:1 stoichiometry to form a chromatosome, contacting linker DNA at the nucleosomal entry/exit site through a central globular domain whose fold resembles that of canonical linker histones, while its N- and C-terminal regions and an embedded HP1-binding motif support chromatin engagement and direct binding to HP1 [PMID:20042602, PMID:25662603]. Unlike canonical H1, its nucleosome occupancy is governed by the histone chaperones NPM1 and TAF-I and by cell-cycle-dependent post-translational modifications, and it preferentially loads at genomic loci bearing active H3 marks rather than inactive chromatin [PMID:25662603, PMID:40140990]. Through this chromatin activity HP1BP3 maintains heterochromatin integrity during G1-S progression and sets G1 duration to control proliferative capacity [PMID:24830416]. A distinct function couples chromatin to RNA processing: HP1BP3 associates with the Drosha-DGCR8 microprocessor at actively transcribed miRNA loci and retains nascent pri-miRNAs on chromatin to promote co-transcriptional miRNA biogenesis [PMID:27425409]. It additionally cooperates with PGC7 at the Meg3 imprinted DMR to antagonize DNMT3A and preserve DNA methylation and chromatin condensation [PMID:39422314]. In vivo, Hp1bp3-null mice show ~60% neonatal lethality, lifelong growth retardation driven non-cell-autonomously through the endocrine IGF-1 axis, and deficits in maternal behavior, anxiety, and cognitive aging [PMID:25662603, PMID:26402843, PMID:27470444, PMID:27460150].","teleology":[{"year":2009,"claim":"Established the structural basis for HP1BP3 as a chromatin protein by showing its middle region forms a chromatosome-like structure on nucleosomes and that it directly binds HP1, defining it as a linker-histone-like, heterochromatin-associated factor.","evidence":"NMR structure of the globular domain, MNase protection on reconstituted mononucleosomes, in vitro direct binding assays","pmids":["20042602"],"confidence":"High","gaps":["Did not establish full-length nucleosome binding stoichiometry","Functional consequence of HP1 binding in cells not addressed"]},{"year":2014,"claim":"Connected HP1BP3 chromatin dynamics to the cell cycle, showing it maintains heterochromatin integrity through G1-S and regulates G1 length and proliferation.","evidence":"Partial MNase digestion with iTRAQ chromatin proteomics and siRNA knockdown with cell-cycle analysis","pmids":["24830416"],"confidence":"Medium","gaps":["Molecular targets controlling G1 duration not identified","Link to a specific transcriptional program unresolved"]},{"year":2014,"claim":"Extended chromatin function to stress physiology, showing HP1BP3-mediated chromatin condensation under hypoxia promotes tumor cell survival, therapy resistance, and self-renewal.","evidence":"DNase I partial digestion with iTRAQ chromatome profiling and loss/gain-of-function functional assays","pmids":["25100860"],"confidence":"Medium","gaps":["Mechanism linking condensation to resistance phenotypes unclear","Upstream hypoxic signal to HP1BP3 unknown"]},{"year":2015,"claim":"Defined HP1BP3 domain architecture and demonstrated organismal requirement, mapping cell-cycle/PTM-regulated chromatin binding and revealing neonatal lethality and growth retardation in knockout mice.","evidence":"FRAP, microarray transcriptional profiling, domain/sequence analysis, and Hp1bp3-/- mouse phenotyping","pmids":["25662603"],"confidence":"Medium","gaps":["Specific PTMs regulating binding not identified","Direct transcriptional targets among the 383 altered genes not mechanistically resolved"]},{"year":2015,"claim":"Identified the basis of the growth phenotype as non-cell-autonomous, implicating HP1BP3 in transcriptional control of the endocrine IGF-1 axis.","evidence":"Hp1bp3-/- mouse microCT, primary osteoblast/osteoclast differentiation, serum IGF-1/IGFBP ELISA, hepatic transcript quantification","pmids":["26402843"],"confidence":"Medium","gaps":["Direct chromatin binding at Igf1/Igfbp loci not demonstrated","Tissue source of the primary defect not pinpointed"]},{"year":2016,"claim":"Revealed a chromatin-to-RNA-processing function: HP1BP3 retains nascent pri-miRNAs on chromatin and delivers them to the Drosha-DGCR8 microprocessor for co-transcriptional processing.","evidence":"Reciprocal Co-IP, ChIP-seq co-localization with Drosha, RIP for pri-miRNAs, and knockdown miRNA profiling","pmids":["27425409"],"confidence":"High","gaps":["How HP1BP3 physically retains transcripts on chromatin not defined","Selectivity for particular miRNA loci unexplained"]},{"year":2016,"claim":"Demonstrated specific in vivo behavioral roles, with knockout females failing pup retrieval and showing altered anxiety without broader behavioral deficits.","evidence":"Hp1bp3-/- pup retrieval, open-field, elevated-plus-maze assays, and co-fostering rescue","pmids":["27470444"],"confidence":"Medium","gaps":["Neural circuits and gene targets underlying behavior unknown","Relation to chromatin/miRNA functions not established"]},{"year":2016,"claim":"Linked HP1BP3 to cognitive aging, with knockout recapitulating age-associated memory deficits.","evidence":"Hp1bp3-/- cognitive behavioral testing and systems genetics in a genetically diverse mouse population","pmids":["27460150"],"confidence":"Medium","gaps":["Molecular pathway connecting HP1BP3 to memory not identified","Whether effect is chromatin- or miRNA-dependent unresolved"]},{"year":2021,"claim":"Provided a downstream effector axis in cancer, with HP1BP3 upregulating miR-23a, which represses TRAF5 to drive esophageal tumor growth and metastasis.","evidence":"Knockdown/overexpression in cell lines and xenografts, miR-23a profiling, and TRAF5 3'UTR luciferase reporter","pmids":["34249436"],"confidence":"Medium","gaps":["How HP1BP3 selectively induces miR-23a not shown","Generality beyond esophageal carcinoma untested"]},{"year":2022,"claim":"Identified an EZH2-HP1BP3 interaction that impairs H3K9 methylation and co-activates WNT7B to drive glioblastoma stemness and drug resistance.","evidence":"Co-IP/mass spectrometry, transcriptomics, gain/loss-of-function assays, and WNT inhibitor (LGK974) rescue","pmids":["36517590"],"confidence":"Medium","gaps":["Direct vs indirect effect on H3K9 methylation not resolved","Whether HP1BP3 binds WNT7B chromatin directly unknown"]},{"year":2024,"claim":"Defined a cooperative HP1BP3-PGC7 mechanism at an imprinted DMR, antagonizing DNMT3A to maintain DNA methylation and chromatin condensation.","evidence":"Co-IP with domain mapping, ChIP, DNMT3A enrichment assays, and bisulfite sequencing under knockdown","pmids":["39422314"],"confidence":"Medium","gaps":["Whether this extends to other imprinted loci unknown","Mechanism of DNMT3A exclusion not biochemically resolved"]},{"year":2025,"claim":"Established HP1BP3 as a bona fide linker histone variant with chaperone-regulated, activity-biased nucleosome binding, distinguishing it from canonical H1.","evidence":"In vitro chromatosome reconstitution with 1:1 NCP binding, NPM1/TAF-I interaction mapping, and ChIP-seq under chaperone knockdown","pmids":["40140990"],"confidence":"High","gaps":["How chaperone regulation integrates with cell-cycle PTMs unresolved","Mechanism directing preference for active chromatin not defined"]},{"year":null,"claim":"It remains unknown how HP1BP3's linker-histone chromatin activity mechanistically unifies its diverse downstream roles in miRNA biogenesis, imprinting, IGF-1 signaling, and behavior.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No single model connects chromatin occupancy to specific transcriptional/miRNA outputs","PTMs and chaperone control not linked to in vivo phenotypes","Direct genomic targets driving organismal phenotypes unidentified"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[0,3,11]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,11]},{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[5]},{"term_id":"GO:0042393","term_label":"histone binding","supporting_discovery_ids":[0,11]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[3,4]}],"localization":[{"term_id":"GO:0005694","term_label":"chromosome","supporting_discovery_ids":[0,1,5,11]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[1,11]}],"pathway":[{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[0,1,11]},{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[5]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[1]}],"complexes":["Drosha-DGCR8 microprocessor","chromatosome"],"partners":["HP1","DROSHA","DGCR8","NPM1","TAF-I","PGC7","EZH2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q5SSJ5","full_name":"Heterochromatin protein 1-binding protein 3","aliases":["Protein HP1-BP74"],"length_aa":553,"mass_kda":61.2,"function":"Component of heterochromatin that maintains heterochromatin integrity during G1/S progression and regulates the duration of G1 phase to critically influence cell proliferative capacity (PubMed:24830416). Mediates chromatin condensation during hypoxia, leading to increased tumor cell viability, radio-resistance, chemo-resistance and self-renewal (PubMed:25100860)","subcellular_location":"Nucleus; Chromosome","url":"https://www.uniprot.org/uniprotkb/Q5SSJ5/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/HP1BP3","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"NUCKS1","stoichiometry":10.0},{"gene":"HMGN5","stoichiometry":4.0},{"gene":"NUMA1","stoichiometry":4.0},{"gene":"ANAPC4","stoichiometry":0.2},{"gene":"ATG13","stoichiometry":0.2},{"gene":"EMC9","stoichiometry":0.2},{"gene":"G3BP2","stoichiometry":0.2},{"gene":"H1F0","stoichiometry":0.2},{"gene":"H2AFZ","stoichiometry":0.2},{"gene":"HIST2H2BE","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/HP1BP3","total_profiled":1310},"omim":[{"mim_id":"616072","title":"HETEROCHROMATIN PROTEIN 1-BINDING PROTEIN 3; HP1BP3","url":"https://www.omim.org/entry/616072"},{"mim_id":"614161","title":"PR DOMAIN-CONTAINING PROTEIN 5; PRDM5","url":"https://www.omim.org/entry/614161"},{"mim_id":"604478","title":"CHROMOBOX 5; CBX5","url":"https://www.omim.org/entry/604478"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nuclear speckles","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/HP1BP3"},"hgnc":{"alias_symbol":["HP1-BP74"],"prev_symbol":[]},"alphafold":{"accession":"Q5SSJ5","domains":[{"cath_id":"1.10.10","chopping":"160-229","consensus_level":"high","plddt":89.283,"start":160,"end":229},{"cath_id":"1.10.10","chopping":"259-270_356-423","consensus_level":"medium","plddt":90.3091,"start":259,"end":423},{"cath_id":"-","chopping":"275-353","consensus_level":"medium","plddt":88.7322,"start":275,"end":353}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q5SSJ5","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q5SSJ5-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q5SSJ5-F1-predicted_aligned_error_v6.png","plddt_mean":65.31},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=HP1BP3","jax_strain_url":"https://www.jax.org/strain/search?query=HP1BP3"},"sequence":{"accession":"Q5SSJ5","fasta_url":"https://rest.uniprot.org/uniprotkb/Q5SSJ5.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q5SSJ5/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q5SSJ5"}},"corpus_meta":[{"pmid":"24830416","id":"PMC_24830416","title":"Profiling of the Chromatin-associated Proteome Identifies HP1BP3 as a Novel Regulator of Cell Cycle Progression.","date":"2014","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/24830416","citation_count":43,"is_preprint":false},{"pmid":"25100860","id":"PMC_25100860","title":"Quantitative profiling of chromatome dynamics reveals a novel role for HP1BP3 in hypoxia-induced oncogenesis.","date":"2014","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/25100860","citation_count":38,"is_preprint":false},{"pmid":"27460150","id":"PMC_27460150","title":"Systems genetics identifies Hp1bp3 as a novel modulator of cognitive aging.","date":"2016","source":"Neurobiology of aging","url":"https://pubmed.ncbi.nlm.nih.gov/27460150","citation_count":32,"is_preprint":false},{"pmid":"27425409","id":"PMC_27425409","title":"HP1BP3, a Chromatin Retention Factor for Co-transcriptional MicroRNA Processing.","date":"2016","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/27425409","citation_count":29,"is_preprint":false},{"pmid":"25662603","id":"PMC_25662603","title":"HP1BP3 is a novel histone H1 related protein with essential roles in viability and growth.","date":"2015","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/25662603","citation_count":27,"is_preprint":false},{"pmid":"36517590","id":"PMC_36517590","title":"EZH2 interacts with HP1BP3 to epigenetically activate WNT7B that promotes temozolomide resistance in glioblastoma.","date":"2022","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/36517590","citation_count":22,"is_preprint":false},{"pmid":"20042602","id":"PMC_20042602","title":"The middle region of an HP1-binding protein, HP1-BP74, associates with linker DNA at the entry/exit site of nucleosomal DNA.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20042602","citation_count":22,"is_preprint":false},{"pmid":"26402843","id":"PMC_26402843","title":"Proportionate Dwarfism in Mice Lacking Heterochromatin Protein 1 Binding Protein 3 (HP1BP3) Is Associated With Alterations in the Endocrine IGF-1 Pathway.","date":"2015","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/26402843","citation_count":14,"is_preprint":false},{"pmid":"27470444","id":"PMC_27470444","title":"HP1BP3 expression determines maternal behavior and offspring survival.","date":"2016","source":"Genes, brain, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/27470444","citation_count":11,"is_preprint":false},{"pmid":"34249436","id":"PMC_34249436","title":"HP1BP3 promotes tumor growth and metastasis by upregulating miR-23a to target TRAF5 in esophageal squamous cell carcinoma.","date":"2021","source":"American journal of cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/34249436","citation_count":10,"is_preprint":false},{"pmid":"28469151","id":"PMC_28469151","title":"The novel transcriptional factor HP1BP3 negatively regulates Hsp70 transcription in Crassostrea hongkongensis.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28469151","citation_count":5,"is_preprint":false},{"pmid":"39422314","id":"PMC_39422314","title":"Interaction of PGC7 and HP1BP3 Maintains Meg3-DMR Methylation by Regulating Chromatin Configuration.","date":"2024","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/39422314","citation_count":1,"is_preprint":false},{"pmid":"40140990","id":"PMC_40140990","title":"Function of HP1BP3 as a linker histone is regulated by linker histone chaperones, NPM1 and TAF-I.","date":"2025","source":"Epigenetics & chromatin","url":"https://pubmed.ncbi.nlm.nih.gov/40140990","citation_count":1,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":8281,"output_tokens":3352,"usd":0.037561,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":10996,"output_tokens":4057,"usd":0.078202,"stage2_stop_reason":"end_turn"},"total_usd":0.115763,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2009,\n      \"finding\": \"HP1BP3 (HP1-BP74) middle region (residues Lys97–Lys274) associates with linker DNA at the entry/exit site of nucleosomal DNA, forming a chromatosome-like structure that protects ~25 bp of linker DNA from MNase digestion. The globular domain (Met153–Thr237) within this region adopts a structure similar to the globular domain of linker histones as determined by NMR. Full-length HP1BP3 directly binds HP1 (heterochromatin protein 1), with exact HP1-binding sites identified.\",\n      \"method\": \"NMR structure determination, MNase protection assay with reconstituted mononucleosomes, in vitro direct binding assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — NMR structure with functional validation by reconstituted in vitro nucleosome binding and MNase protection assay, multiple orthogonal methods in a single study\",\n      \"pmids\": [\"20042602\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"HP1BP3 dynamically associates with chromatin during interphase progression; it maintains heterochromatin integrity during G1-S progression and regulates the duration of G1 phase to influence cell proliferative capacity.\",\n      \"method\": \"Partial MNase digestion coupled with iTRAQ quantitative proteomics, biochemical fractionation, functional cell-cycle assays (siRNA knockdown with cell-cycle analysis)\",\n      \"journal\": \"Molecular & cellular proteomics : MCP\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — quantitative chromatin proteomics combined with functional knockdown and cell-cycle readout, single lab, two orthogonal methods\",\n      \"pmids\": [\"24830416\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"HP1BP3 mediates chromatin condensation during hypoxia, leading to increased tumor cell viability, radio-resistance, chemo-resistance, and self-renewal. Its chromatin association topology changes under hypoxic versus normoxic conditions.\",\n      \"method\": \"DNase I partial digestion with iTRAQ quantitative proteomics, functional assays (cell viability, clonogenic survival, sphere formation under knockdown/overexpression)\",\n      \"journal\": \"Molecular & cellular proteomics : MCP\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — quantitative chromatome profiling combined with functional loss-of-function assays, single lab, two orthogonal methods\",\n      \"pmids\": [\"25100860\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"HP1BP3 is structurally related to the linker histone H1 family, containing three globular domains and a positively charged C-terminal domain. FRAP studies demonstrate that chromatin binding depends on both its C- and N-terminal regions and is regulated by cell cycle stage and post-translational modifications. HP1BP3 contains functional motifs absent from canonical H1, including an acidic stretch and a consensus HP1-binding motif. Knockdown in HeLa cells alters expression of 383 genes. Hp1bp3−/− mice exhibit 60% neonatal lethality and lifelong ~20% growth retardation.\",\n      \"method\": \"FRAP (live-cell imaging), transcriptional profiling (microarray), mouse knockout phenotyping, domain analysis/sequence comparison\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — FRAP with functional domain dissection, knockout mouse phenotype, and transcriptome profiling; single lab but multiple orthogonal methods\",\n      \"pmids\": [\"25662603\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Hp1bp3−/− mice are proportionate dwarfs with severely impaired cortical and trabecular bone development. Primary osteoblast and osteoclast cultures from Hp1bp3−/− mice showed normal differentiation, indicating the growth defect is non-cell-autonomous. These mice exhibit ~60% reduction in circulating IGF-1 and ~4-fold increase in IGFBP-1 and IGFBP-2, with corresponding changes in hepatic transcripts of Igf1, Igfbp1, and Igfbp2, implicating HP1BP3 in transcriptional regulation of the endocrine IGF-1 axis.\",\n      \"method\": \"Hp1bp3−/− mouse knockout, microCT bone analysis, primary cell culture differentiation assays, ELISA for serum IGF-1/IGFBPs, hepatic transcript quantification\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic loss-of-function with multiple orthogonal readouts (bone imaging, endocrine assays, transcriptomics), single lab\",\n      \"pmids\": [\"26402843\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"HP1BP3 specifically associates with the Drosha-DGCR8 microprocessor complex, co-localizes genome-wide with Drosha at actively transcribed miRNA loci (by ChIP), binds endogenous pri-miRNAs, and facilitates the Drosha/pri-miRNA association in vivo. Knockdown of HP1BP3 causes premature release of nascent pri-miRNAs from chromatin, impairing global miRNA biogenesis. HP1BP3 thus functions as a chromatin retention factor for co-transcriptional miRNA processing.\",\n      \"method\": \"Co-immunoprecipitation (Co-IP), chromatin immunoprecipitation (ChIP-seq), RNA immunoprecipitation (RIP), siRNA knockdown with miRNA profiling\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP, genome-wide ChIP, RIP, and functional knockdown with miRNA profiling; multiple orthogonal methods establishing mechanism\",\n      \"pmids\": [\"27425409\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Deletion of Hp1bp3 in female mice causes failure to retrieve pups and reduced anxiety-like behavior without deficits in social behavior, depression, motor coordination, or olfactory capability, identifying a specific role for HP1BP3 in maternal and anxiety-related behavior.\",\n      \"method\": \"Hp1bp3−/− mouse knockout, pup retrieval behavioral assay, open-field and elevated-plus-maze tests, co-fostering rescue experiment\",\n      \"journal\": \"Genes, brain, and behavior\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic knockout with multiple behavioral assays and rescue experiment, single lab\",\n      \"pmids\": [\"27470444\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Deletion of functional Hp1bp3 in mice recapitulates memory deficits characteristic of aged impaired mice and humans, establishing HP1BP3 as a modulator of cognitive aging.\",\n      \"method\": \"Hp1bp3−/− mouse knockout, cognitive behavioral testing (memory assays), systems genetics using genetically diverse mouse population\",\n      \"journal\": \"Neurobiology of aging\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic knockout with cognitive behavioral phenotype in a genetically diverse mouse population, single lab\",\n      \"pmids\": [\"27460150\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"HP1BP3 promotes tumor growth and metastasis in esophageal squamous cell carcinoma by upregulating miR-23a, which directly binds to the 3′UTR of TRAF5, thereby altering cell survival and proliferation downstream.\",\n      \"method\": \"HP1BP3 knockdown/overexpression in cancer cell lines and xenograft models, miR-23a profiling, 3′UTR luciferase reporter assay for TRAF5\",\n      \"journal\": \"American journal of cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional knockdown/overexpression with in vivo xenograft, luciferase reporter for direct miR-23a/TRAF5 interaction, single lab\",\n      \"pmids\": [\"34249436\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"EZH2 physically interacts with HP1BP3 in glioma stem cells, and this interaction impairs H3K9 methylation. EZH2 and HP1BP3 co-activate WNT7B expression, promoting temozolomide resistance and stemness in glioblastoma cells.\",\n      \"method\": \"Co-immunoprecipitation (Co-IP) followed by mass spectrometry, transcriptomic analysis, overexpression/knockdown functional assays, WNT pathway inhibitor (LGK974) rescue\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP/MS identification of EZH2-HP1BP3 interaction, functional assays with pharmacological rescue, single lab\",\n      \"pmids\": [\"36517590\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"HP1BP3 interacts with PGC7 through its central globular domain (PGC7 binds via its C-terminal tail). HP1BP3 recruits PGC7 to the Meg3 differentially methylated region (DMR) in the Dlk1-Dio3 imprinted domain. Cooperative binding of PGC7 and HP1BP3 antagonizes DNMT3A enrichment at the Meg3-DMR, maintaining DNA methylation status. Depletion of either HP1BP3 or PGC7 leads to chromosome decondensation at this region.\",\n      \"method\": \"Co-immunoprecipitation, domain-mapping interaction assays, ChIP, DNMT3A enrichment assays, bisulfite sequencing for DNA methylation, knockdown phenotyping\",\n      \"journal\": \"Journal of cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP with domain mapping, ChIP, and DNA methylation analysis; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"39422314\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"HP1BP3 functions as a linker histone variant: it efficiently binds to nucleosome core particles (NCPs) forming a chromatosome, with a single HP1BP3 molecule binding a single NCP. Its NCP binding activity is regulated by linker histone chaperones NPM1 and TAF-I, which interact with the globular domains and C-terminal disordered region of HP1BP3. ChIP-seq shows HP1BP3 preferentially associates with genomic loci enriched for active histone H3 modification marks, in contrast to linker histone H1.2 which prefers inactive loci; these preferences are diminished upon NPM1 or TAF-I knockdown.\",\n      \"method\": \"Biochemical NCP-binding assays, chromatosome reconstitution, co-immunoprecipitation for chaperone interactions, ChIP-seq, siRNA knockdown\",\n      \"journal\": \"Epigenetics & chromatin\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution of chromatosome formation, biochemical chaperone-interaction mapping, genome-wide ChIP-seq; multiple orthogonal methods in a single rigorous study\",\n      \"pmids\": [\"40140990\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"HP1BP3 is a linker histone H1-like chromatin protein that binds nucleosome core particles (forming a chromatosome via its central globular domain and linker DNA contacts), whose chromatin occupancy is regulated by chaperones NPM1 and TAF-I and by cell cycle-dependent post-translational modifications; it directly binds HP1 and PGC7, recruits the Drosha-DGCR8 microprocessor to actively transcribed miRNA loci to promote co-transcriptional pri-miRNA processing by retaining nascent transcripts on chromatin, maintains heterochromatin integrity during G1-S to regulate G1 duration, cooperates with PGC7 to antagonize DNMT3A at imprinted DMRs, interacts with EZH2 to co-activate WNT7B, and is required in vivo for neonatal survival, postnatal growth (via the endocrine IGF-1 axis), cognitive function, and maternal behavior.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"HP1BP3 is a linker histone H1-like chromatin protein that organizes higher-order chromatin and couples chromatin state to gene regulation, cell proliferation, and organismal physiology [#0, #3, #11]. It binds the nucleosome core particle in a 1:1 stoichiometry to form a chromatosome, contacting linker DNA at the nucleosomal entry/exit site through a central globular domain whose fold resembles that of canonical linker histones, while its N- and C-terminal regions and an embedded HP1-binding motif support chromatin engagement and direct binding to HP1 [#0, #3]. Unlike canonical H1, its nucleosome occupancy is governed by the histone chaperones NPM1 and TAF-I and by cell-cycle-dependent post-translational modifications, and it preferentially loads at genomic loci bearing active H3 marks rather than inactive chromatin [#3, #11]. Through this chromatin activity HP1BP3 maintains heterochromatin integrity during G1-S progression and sets G1 duration to control proliferative capacity [#1]. A distinct function couples chromatin to RNA processing: HP1BP3 associates with the Drosha-DGCR8 microprocessor at actively transcribed miRNA loci and retains nascent pri-miRNAs on chromatin to promote co-transcriptional miRNA biogenesis [#5]. It additionally cooperates with PGC7 at the Meg3 imprinted DMR to antagonize DNMT3A and preserve DNA methylation and chromatin condensation [#10]. In vivo, Hp1bp3-null mice show ~60% neonatal lethality, lifelong growth retardation driven non-cell-autonomously through the endocrine IGF-1 axis, and deficits in maternal behavior, anxiety, and cognitive aging [#3, #4, #6, #7].\",\n  \"teleology\": [\n    {\n      \"year\": 2009,\n      \"claim\": \"Established the structural basis for HP1BP3 as a chromatin protein by showing its middle region forms a chromatosome-like structure on nucleosomes and that it directly binds HP1, defining it as a linker-histone-like, heterochromatin-associated factor.\",\n      \"evidence\": \"NMR structure of the globular domain, MNase protection on reconstituted mononucleosomes, in vitro direct binding assays\",\n      \"pmids\": [\"20042602\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish full-length nucleosome binding stoichiometry\", \"Functional consequence of HP1 binding in cells not addressed\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Connected HP1BP3 chromatin dynamics to the cell cycle, showing it maintains heterochromatin integrity through G1-S and regulates G1 length and proliferation.\",\n      \"evidence\": \"Partial MNase digestion with iTRAQ chromatin proteomics and siRNA knockdown with cell-cycle analysis\",\n      \"pmids\": [\"24830416\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular targets controlling G1 duration not identified\", \"Link to a specific transcriptional program unresolved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Extended chromatin function to stress physiology, showing HP1BP3-mediated chromatin condensation under hypoxia promotes tumor cell survival, therapy resistance, and self-renewal.\",\n      \"evidence\": \"DNase I partial digestion with iTRAQ chromatome profiling and loss/gain-of-function functional assays\",\n      \"pmids\": [\"25100860\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism linking condensation to resistance phenotypes unclear\", \"Upstream hypoxic signal to HP1BP3 unknown\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Defined HP1BP3 domain architecture and demonstrated organismal requirement, mapping cell-cycle/PTM-regulated chromatin binding and revealing neonatal lethality and growth retardation in knockout mice.\",\n      \"evidence\": \"FRAP, microarray transcriptional profiling, domain/sequence analysis, and Hp1bp3-/- mouse phenotyping\",\n      \"pmids\": [\"25662603\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Specific PTMs regulating binding not identified\", \"Direct transcriptional targets among the 383 altered genes not mechanistically resolved\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Identified the basis of the growth phenotype as non-cell-autonomous, implicating HP1BP3 in transcriptional control of the endocrine IGF-1 axis.\",\n      \"evidence\": \"Hp1bp3-/- mouse microCT, primary osteoblast/osteoclast differentiation, serum IGF-1/IGFBP ELISA, hepatic transcript quantification\",\n      \"pmids\": [\"26402843\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct chromatin binding at Igf1/Igfbp loci not demonstrated\", \"Tissue source of the primary defect not pinpointed\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Revealed a chromatin-to-RNA-processing function: HP1BP3 retains nascent pri-miRNAs on chromatin and delivers them to the Drosha-DGCR8 microprocessor for co-transcriptional processing.\",\n      \"evidence\": \"Reciprocal Co-IP, ChIP-seq co-localization with Drosha, RIP for pri-miRNAs, and knockdown miRNA profiling\",\n      \"pmids\": [\"27425409\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How HP1BP3 physically retains transcripts on chromatin not defined\", \"Selectivity for particular miRNA loci unexplained\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Demonstrated specific in vivo behavioral roles, with knockout females failing pup retrieval and showing altered anxiety without broader behavioral deficits.\",\n      \"evidence\": \"Hp1bp3-/- pup retrieval, open-field, elevated-plus-maze assays, and co-fostering rescue\",\n      \"pmids\": [\"27470444\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Neural circuits and gene targets underlying behavior unknown\", \"Relation to chromatin/miRNA functions not established\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Linked HP1BP3 to cognitive aging, with knockout recapitulating age-associated memory deficits.\",\n      \"evidence\": \"Hp1bp3-/- cognitive behavioral testing and systems genetics in a genetically diverse mouse population\",\n      \"pmids\": [\"27460150\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular pathway connecting HP1BP3 to memory not identified\", \"Whether effect is chromatin- or miRNA-dependent unresolved\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Provided a downstream effector axis in cancer, with HP1BP3 upregulating miR-23a, which represses TRAF5 to drive esophageal tumor growth and metastasis.\",\n      \"evidence\": \"Knockdown/overexpression in cell lines and xenografts, miR-23a profiling, and TRAF5 3'UTR luciferase reporter\",\n      \"pmids\": [\"34249436\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"How HP1BP3 selectively induces miR-23a not shown\", \"Generality beyond esophageal carcinoma untested\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Identified an EZH2-HP1BP3 interaction that impairs H3K9 methylation and co-activates WNT7B to drive glioblastoma stemness and drug resistance.\",\n      \"evidence\": \"Co-IP/mass spectrometry, transcriptomics, gain/loss-of-function assays, and WNT inhibitor (LGK974) rescue\",\n      \"pmids\": [\"36517590\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct vs indirect effect on H3K9 methylation not resolved\", \"Whether HP1BP3 binds WNT7B chromatin directly unknown\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Defined a cooperative HP1BP3-PGC7 mechanism at an imprinted DMR, antagonizing DNMT3A to maintain DNA methylation and chromatin condensation.\",\n      \"evidence\": \"Co-IP with domain mapping, ChIP, DNMT3A enrichment assays, and bisulfite sequencing under knockdown\",\n      \"pmids\": [\"39422314\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether this extends to other imprinted loci unknown\", \"Mechanism of DNMT3A exclusion not biochemically resolved\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Established HP1BP3 as a bona fide linker histone variant with chaperone-regulated, activity-biased nucleosome binding, distinguishing it from canonical H1.\",\n      \"evidence\": \"In vitro chromatosome reconstitution with 1:1 NCP binding, NPM1/TAF-I interaction mapping, and ChIP-seq under chaperone knockdown\",\n      \"pmids\": [\"40140990\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How chaperone regulation integrates with cell-cycle PTMs unresolved\", \"Mechanism directing preference for active chromatin not defined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unknown how HP1BP3's linker-histone chromatin activity mechanistically unifies its diverse downstream roles in miRNA biogenesis, imprinting, IGF-1 signaling, and behavior.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No single model connects chromatin occupancy to specific transcriptional/miRNA outputs\", \"PTMs and chaperone control not linked to in vivo phenotypes\", \"Direct genomic targets driving organismal phenotypes unidentified\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [0, 3, 11]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 11]},\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [5]},\n      {\"term_id\": \"GO:0042393\", \"supporting_discovery_ids\": [0, 11]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [3, 4]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005694\", \"supporting_discovery_ids\": [0, 1, 5, 11]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [1, 11]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [0, 1, 11]},\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [5]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [1]}\n    ],\n    \"complexes\": [\"Drosha-DGCR8 microprocessor\", \"chromatosome\"],\n    \"partners\": [\"HP1\", \"DROSHA\", \"DGCR8\", \"NPM1\", \"TAF-I\", \"PGC7\", \"EZH2\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}